<DOC>
	<DOCNO>NCT02550600</DOCNO>
	<brief_summary>The purpose study compare effect interventional Lung Assist iLA activve standard therapy mechanically ventilate patient severe acute lung impairment . Hypothesis : iLA ( active ) reduce incidence increase SOFA-Score ≥3 point ( death ) within 28 day compare standard treatment .</brief_summary>
	<brief_title>Extracorporeal Lung Assist Device Acute Lung Impairment</brief_title>
	<detailed_description>Background : Mechanical ventilation patient acute lung impairment injures lungs inspiration force inflammatory response . Large effort invest reduce ventilator-associated lung damage low tidal volume . However , benefit limit potential harm permissive hypercapnia . Therefore , extracorporeal membrane oxygenation ( ECMO ) CO2-removal study 40 year . However , ECMO remain restricted specialized centre capable provide extensive resource . Transfer patient implicate loss time risks transportation . Therefore , less invasive device develop , include `` pump-less `` extracorporeal lung assist '' ( pECLA ) pump-driven ECLA ( e.g . iLA activve ) . Despite pilot trial support feasibility , safety efficient oxygenation decarboxylation pump-driven ECLA , randomize control trial ( RCT ) prove benefit regard long-term endpoint . Objectives : Therefore , aim multicentre RCT compare outcome 150 patient early ( ≤96h mechanical ventilation ) acute lung impairment treat pump-driven ECLA iLA activve blood flow least 1L/min vs. 150 control standard intensive care include low tidal volume ventilation . Main inclusion exclusion criterion : While trial ECMO ( p ) ECLA include patient rescue scenario severe persisting ARDS , early inclusion also implicate modified inclusion criterion : A cumulative Murray score ≥6 point without radiological point important inclusion criterion . At least four point must result pO2/FiO2 ( mandatory pO2/FiO2 &lt; 300mmHg ) PEEP criterion Murray score . In order provide sufficient time conservative attempt optimize ventilation , inclusion criterion fulfil maximum 48h inclusion long patient include within maximum 96h mechanical ventilation . Primary efficacy endpoint : Incidence increase SOFA-Score ≥3 point death within 28 day . Statistical analysis : Generalized linear mixed model ( logit link function ) use compare primary efficacy endpoint , proportion patient increase SOFA ≥3 point death within 28d , two group . In analysis random factor variable study centre anticoagulation therapy consider adjustment variable . The test group effect estimate multivariable mixed logistic model conduct two-sided 0.05 level significance . The primary efficacy analysis base intention-to-treat population . Missing value SOFA score replace last-value carry forward approach . Survival status lose follow-up patient replace conservatively : miss survival status replace attribute `` death '' patient verum arm replace attribute `` alive '' patient standard treatment arm . A supportive complete case per-protocol analysis conduct purpose sensitivity analysis primary endpoint . Further sensitivity analysis provide evaluate robustness result regard unexpected circumstance ( e.g . impact 'cross-over ' patient treat randomize require analyzed randomize ( ITT-principle ) ) . Secondary endpoint analyze exploratory manner . Chi-Square test Fisher-exact test use compare categorical data . For comparison continuous data group non-parametric test ( Kruskal-Wallis test , Mann-Whitney-U test ) perform . 95 % confidence interval calculate relevant measurement . SAS software ( version 4.9 future follow-up version ) .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>Potentially reversible lung failure AND Cumulative Murray score ≥6 point without radiological point maximum 48h AND Cumulative Murray score ≥4 point pO2/FiO PEEP AND Cumulative Murray score ≥1 point pO2/FiO Mechanical ventilation ≤96h AND Age ≥ 18 year . SOFAScore &gt; 20 Life expectancy &lt; 24h mechanical ventilation &gt; 96h Heparininduced thrombopenia Intracranial bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>ARDS</keyword>
	<keyword>Acute lung impairment</keyword>
	<keyword>Extracorporeal lung assist</keyword>
	<keyword>ECMO</keyword>
	<keyword>ECLA</keyword>
	<keyword>Murray-score</keyword>
	<keyword>SOFA-score</keyword>
</DOC>